The evolution of long-term pediatric ventricular assistance devices: a critical review.
Louis MarcelMathieu SpecklinSmaïne KouidriPublished in: Expert review of medical devices (2021)
Introduction: The gap between the number of heart failure patients and the number of potential heart donors has never been larger than today, especially among the pediatric population. The use of mechanical circulatory support is seen as a potential alternative for clinicians to treat more patients. This treatment has proven its efficiency on short-term use. However, in order to replace heart transplant, the techniques should be used over longer periods of time.Areas covered: This review aims at furnishing an engineering vision of the evolution of ventricular assistance devices used in pediatrics. A critical analysis of the clinical complications related to devices generation is made to give an overview of the design improvements made since their inception.Expert opinion: The long-term use of a foreign device in the body is not without consequences, especially among fragile pediatric patients. Moreover, the size of their body parts increases the technical difficulties of such procedure. The balance between the living cells of the body is disturbed by the devices, mostly by the shear stress generated. To provide a safe mechanical circulatory support for long-term use, the devices should be more hemocompatible, preserving blood cells, adapted to the patient's systemic grid and miniaturized for pediatric use.
Keyphrases
- living cells
- heart failure
- ejection fraction
- newly diagnosed
- left ventricular
- fluorescent probe
- induced apoptosis
- extracorporeal membrane oxygenation
- atrial fibrillation
- risk factors
- palliative care
- single molecule
- minimally invasive
- cell death
- case report
- cell cycle arrest
- signaling pathway
- young adults
- clinical practice
- endoplasmic reticulum stress
- kidney transplantation
- combination therapy
- chronic kidney disease